BSN medical’s sales and EBITDA for 2016

Report this content

As SCA communicated in December 2016, the Group has entered into an agreement to acquire BSN medical, a leading medical solutions company. Closing is expected to take place during the second quarter 2017. BSN medical’s sales for 2016 amounted to EUR 850m (SEK 8,038m) and adjusted EBITDA1) for 2016 amounted to EUR 210m (SEK 1,986m).

1)Excluding items affecting comparability

NB: This information is information that SCA is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 20:00 CET on March 9, 2017. 

Karl Stoltz, Media Relations Manager, +46 8 788 51 55  

For additional information please contact:
Johan Karlsson, Vice President Investor Relations, 46 (0)8 788 51 30
Karl Stoltz, Media Relations Manager, 46 (0)8 788 51 55

SCA is a leading global hygiene and forest products company that sustainably develops, produces, markets and sells personal care, tissue and forest products. Sales are conducted in about 100 countries under many strong brands, including the leading global brands TENA and Tork, and regional brands, such as Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa. As Europe’s largest private forest owner, SCA places considerable emphasis on sustainable forest management. The Group has about 46,000 employees. Sales in 2016 amounted to approximately SEK 117bn (EUR 12.4bn). SCA was founded in 1929, has its headquarters in Stockholm, Sweden, and is listed on NASDAQ Stockholm. More information at www.sca.com.